MeSH D017118 - acute intermittent porphyria
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Chlorpromazine | Chlorpromazine | 1982-01-01 | |||
| Glenmark Pharmaceuticals | Chlorpromazine | Chlorpromazine | 2021-03-23 | |||
| GSK | Chlorpromazine | Thorazine | 1982-01-01 | |||
| Chartwell Pharmaceuticals | Chlorpromazine | Chlorpromazine | 1982-01-01 | |||
| Chlorpromazine | Sonazine | 1982-01-01 | ||||
| Wyeth | Chlorpromazine | Chlorpromazine | 1982-01-01 | |||
| Alpharma | Chlorpromazine | Chlorpromazine | 1982-01-01 | |||
| Genus Lifesciences | Chlorpromazine | Chlorpromazine | 2021-06-02 | |||
| Pfizer | Chlorpromazine | Promapar | 1982-01-01 | |||
| Dr Reddys Laboratories | Chlorpromazine | Chlorpromazine | 1982-01-01 | |||
| Zydus Therapeutics | Chlorpromazine | Chlorpromazine | 2020-01-17 |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
67%2/3
Phase 2
67%2/3
Phase 3
33%1/3
Approved: 1Overall Success rate: 15%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use